Share
6 min read
therapiesEvidence-based

MIT's "Disco Light" Brain Therapy: What Every APOE4 Carrier Needs to Know about Red Light Therapy

All your questions about Photobiomodulation answered

T
· Reviewed by Dr. Kevin Tran, PharmD

Key takeaways · TL;DR

1070nm near-infrared photobiomodulation for 10 minutes daily produces measurable brain changes in 3 to 4 weeks, addressing the three main APOE4 vulnerabilities: reduced waste clearance, mitochondrial dysfunction, and chronic neuroinflammation. MIT Dr. Li-Huei Tsai parallel 40Hz light approach clears amyloid via the glymphatic system and is now in Phase 3 trials through Cognito Therapeutics.

Definition

Near-infrared light therapy at 1070 nanometers. It stimulates mitochondrial ATP production and enhances cerebral blood flow.

Definition

The brain waste clearance pathway. It flushes amyloid and tau through cerebrospinal fluid, mostly during deep sleep.

Two Red Light Alzheimer Approaches

ApproachMechanismStatus
Neuronic 1070nm continuousMitochondrial ATP + nitric oxide vasodilationAvailable; 10 min daily protocol
MIT 40Hz flicker (Cognito)Glymphatic amyloid clearance via gamma entrainmentPhase 3 clinical trials

If you're carrying APOE4, you've heard it all: "Just eat well and exercise." "We'll know more in 10 years." "There's nothing definitive."

A few days ago, we hosted Chris Garvin from Neuronic, revealing data that challenges everything we thought we knew about E4 and brain intervention.

Can a helmet improve brain health?

1070nm near-infrared light, applied for just 10 minutes daily, produces measurable brain changes in 3-4 weeks.

Not years. Not months. Weeks.

Here's what the evidence shows:

The Science

University of Texas Arlington Study (Science Advances, 2022):

  • 90 healthy adults tested

  • Significant working memory improvements

  • Right prefrontal cortex targeting = maximum effect

MIT's Parallel Discovery (Dr. Li-Huei Tsai):

  • 40Hz light clears amyloid via glymphatic system

  • Same mechanism, different approach

  • Currently in Phase 3 trials via Cognito Therapeutics

Why APOE4 Carriers Respond Better

Your E4 brain has three specific vulnerabilities that photobiomodulation directly addresses:

  1. Compromised Waste Clearance (55-65% reduced) → Light triggers nitric oxide → vasodilation → enhanced clearance

  2. Mitochondrial Dysfunction → Direct ATP production stimulation → energy crisis resolved

  3. Chronic Neuroinflammation → Microglial phenotype shift → inflammation reduction

The Practical Protocol

Device: Neuronic 1070nm helmet
Duration: 10 minutes daily
Timing: Morning optimal
Results Timeline: 3-4 weeks for subjective changes
Investment: $1,795 (get 10% off with THEPHOENIX)
Risk Mitigation: 3-month money-back guarantee

Who's Already Using This?

  • Cleveland Clinic ($15M research investment)

  • NFL players (concussion prevention)

  • Long COVID brain fog sufferers

  • Early-stage Alzheimer's patients

  • Preventive biohackers

The Critical Questions

Before you invest in ANY intervention, you need a framework for evaluation. That's exactly what we're covering tomorrow.

Join Us Live: Dr. Hussein Yassine, USC.
APOE4 - Smart Science for Actionable Prevention

Friday, August 15th - Exclusive Phoenix Community Q&ASession

Dr. Yassine, Director of USC's Center for Personalized Brain Health, will teach you:

  1. How to evaluate studies (RCTs vs. observational vs. mechanistic)

  2. When to act on early evidence vs. wait for robust data (the E4 carrier's dilemma)

  3. How to design safe self-experiments (tracking, biomarkers, safety)

  4. Which interventions deserve your attention NOW

His lab has discovered:

  • Small HDL particles in CSF are protective (developing peptide agents)

  • cPLA₂ enzyme drives E4 inflammation (new blockers 100x more potent)

  • ABCA1 pathway restoration as drug target

This is your chance to ask the tough questions directly to a leading APOE4 researcher.

Why Phoenix?

We're not waiting for pharmaceutical salvation. We're running structured experiments, sharing data, and discovering what actually works.

Inside the Phoenix, you get:

  • Direct access to experts like Chris Garvin and Dr. Hussein Yassine

  • Community-verified protocols and results

  • Group buying power to buy devices like Neuronic’s at a discounted price

  • Structured experiment frameworks

  • Real-time support from hundreds E4 carriers taking action

  • And more :)

Ready to stop hoping and start doing?

Sources:
Chris Garvin, from Neuronic

Filed under
therapiescognitionresearch

Discussion

Join the conversation

Your email will never be published. Be respectful and constructive.

FAQ

Frequently asked questions.

How does red light therapy help APOE4 brains?
APOE4 brains have three specific vulnerabilities that photobiomodulation directly addresses. First, APOE4 carriers have 55 to 65 percent reduced waste clearance, and red light triggers nitric oxide release which drives vasodilation and enhanced glymphatic clearance. Second, mitochondrial dysfunction in APOE4 neurons is corrected by direct ATP production stimulation from 1070nm wavelength absorption. Third, chronic neuroinflammation is reduced by a microglial phenotype shift from pro-inflammatory to anti-inflammatory states. Each mechanism maps onto a known APOE4 pathological pathway.
What is the MIT 40Hz disco light therapy for Alzheimer?
Dr. Li-Huei Tsai at MIT discovered that 40Hz light flickering, dubbed disco light therapy, clears amyloid plaques in animal models via the glymphatic system, the brain waste clearance pathway that works primarily during sleep. The mechanism is different from the thermal and mitochondrial effects of continuous 1070nm near-infrared light, but the two approaches converge on improved waste clearance. Cognito Therapeutics is currently running Phase 3 clinical trials of the MIT approach, and early-stage Alzheimer patients are already enrolled.
What does the research say about photobiomodulation and cognition?
A University of Texas Arlington study published in Science Advances in 2022 tested 90 healthy adults and found significant working memory improvements when 1070nm light was targeted at the right prefrontal cortex. In Alzheimer mouse models, 1070nm light reduces amyloid burden and increases cerebral blood vessel density. Cleveland Clinic has committed $15 million to photobiomodulation research. NFL players are using it for concussion recovery, long COVID patients for brain fog, and early-stage Alzheimer patients as adjunct therapy. The evidence base is expanding rapidly.
What is the Neuronic photobiomodulation protocol?
The Neuronic LIGHT helmet delivers 1070nm near-infrared light for 10 minutes daily, ideally in the morning. Measurable subjective changes typically appear in 3 to 4 weeks, not months or years. The device retails at $1,795 with a 10 percent Phoenix discount code and a 3-month money-back guarantee to mitigate financial risk. Phoenix Community separately negotiated a larger member discount through a structured study partnership where participants receive the device at manufacturer cost in exchange for contributing anonymized outcome data.
What is Dr. Hussein Yassine researching at USC?
Dr. Hussein Yassine directs the USC Center for Personalized Brain Health and studies three APOE4-specific mechanisms. First, small HDL particles in cerebrospinal fluid appear protective, and his lab is developing peptide agents to boost them. Second, the cPLA2 enzyme drives APOE4 inflammation, and his team has identified new blockers 100 times more potent than existing ones. Third, the ABCA1 cholesterol efflux pathway is a promising drug target for restoring APOE4 lipid function. These three mechanisms represent the next wave of APOE4-specific therapeutics.
Can a helmet improve brain health?
1070nm near-infrared light, applied for just 10 minutes daily, produces measurable brain changes in 3-4 weeks. Not years. Not months. Weeks. Here's what the evidence shows:
Why APOE4 Carriers Respond Better
Your E4 brain has three specific vulnerabilities that photobiomodulation directly addresses: Compromised Waste Clearance (55-65% reduced) → Light triggers nitric oxide → vasodilation → enhanced clearance Mitochondrial Dysfunction → Direct ATP production stimulation → energy crisis resolved Chronic Neuroinflammation → Microglial phenotype shift → inflammation reduction
Who's Already Using This?
Cleveland Clinic ($15M research investment) NFL players (concussion prevention) Long COVID brain fog sufferers Early-stage Alzheimer's patients Preventive biohackers
Why Phoenix?
We're not waiting for pharmaceutical salvation. We're running structured experiments, sharing data, and discovering what actually works. Inside the Phoenix, you get: Direct access to experts like Chris Garvin and Dr. Hussein Yassine Community-verified protocols and results Group buying power to buy devices like Neuronic’s at a discounted price Structured experiment frameworks Real-time support from hundreds E4 carriers taking action And more :) Ready to stop hoping and start doing? Join the phoenix community here Sources: Chris Garvin, from Neuronic
Keep reading

Related protocols.